Phase I Trial of Brentuximab Vedotin for Steroid Refractory Acute Graft vs. Host Disease (GvHD)
Phase of Trial: Phase I
Latest Information Update: 02 Aug 2018
At a glance
- Drugs Brentuximab vedotin (Primary)
- Indications Graft-versus-host disease
- Focus Adverse reactions
- 10 Jun 2017 Biomarkers information updated
- 21 Mar 2017 Status changed from active, no longer recruiting to completed.
- 03 Oct 2016 Status changed from recruiting to active, no longer recruiting.